PCN29 ECONOMIC EVALUATION OF SUNITINIB FIRST-LINE FOR METASTATIC RENAL CELL CARCINOMAVERSUS SORAFENIB, TEMSIROLIMUS AND BEVACIZUMAB INTERFERON-ALFA IN THE SWEDISH HEALTH SERVICE SETTING
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66566-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)66566-7/fulltext
Title :
PCN29 ECONOMIC EVALUATION OF SUNITINIB FIRST-LINE FOR METASTATIC RENAL CELL CARCINOMAVERSUS SORAFENIB, TEMSIROLIMUS AND BEVACIZUMAB INTERFERON-ALFA IN THE SWEDISH HEALTH SERVICE SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66566-7&doi=10.1016/S1098-3015(10)66566-7
First page :
Section Title :
Open access? :
No
Section Order :
400